Overview

Psilocybin-assisted Therapy for Alcohol Use Disorder

Status:
NOT_YET_RECRUITING
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
To explore the effectiveness of psilocybin-assisted therapy on reducing alcohol consumption in a double-blind, randomised, phase II clinical trial.
Phase:
PHASE2
Details
Lead Sponsor:
University of Sydney
Collaborator:
Woke Pharmaceuticals
Treatments:
Niacin
Psilocybin